ARCHIVES

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed

January 27, 1989

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

High-Priority Radiation Therapy Research Projects Approved By DCT Board of Counselors

March 26, 1976